Terms: = Endocrine gland cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Treatment
15 results:
1. Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
Jiang Z; Wu F; Laise P; Takayuki T; Na F; Kim W; Kobayashi H; Chang W; Takahashi R; Valenti G; Sunagawa M; White RA; Macchini M; Renz BW; Middelhoff M; Hayakawa Y; Dubeykovskaya ZA; Tan X; Chu TH; Nagar K; Tailor Y; Belin BR; Anand A; Asfaha S; Finlayson MO; Iuga AC; Califano A; Wang TC
Cell Stem Cell; 2023 Aug; 30(8):1091-1109.e7. PubMed ID: 37541213
[TBL] [Abstract] [Full Text] [Related]
2. The Application of 18 F-fes PET in Clinical cancer Care : A Systematic Review.
Huang YT; Chen TW; Chen LY; Huang YY; Lu YS
Clin Nucl Med; 2023 Sep; 48(9):785-795. PubMed ID: 37482660
[TBL] [Abstract] [Full Text] [Related]
3. Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.
Gan Y; Liu T; Feng W; Wang L; Li LI; Ning Y
Oncol Res; 2023; 31(3):333-343. PubMed ID: 37305383
[TBL] [Abstract] [Full Text] [Related]
4. Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma.
Feng Z; Shao D; Cai Y; Bi R; Ju X; Chen D; Song C; Chen X; Li J; An N; Li Y; Zhou Q; Xiu Z; Zhu S; Wu X; Wen H
J Ovarian Res; 2023 Mar; 16(1):53. PubMed ID: 36922847
[TBL] [Abstract] [Full Text] [Related]
5. An Anticancer Rhenium Tricarbonyl Targets Fe-S Cluster Biogenesis in Ovarian cancer Cells.
Neuditschko B; King AP; Huang Z; Janker L; Bileck A; Borutzki Y; Marker SC; Gerner C; Wilson JJ; Meier-Menches SM
Angew Chem Int Ed Engl; 2022 Oct; 61(43):e202209136. PubMed ID: 36004624
[TBL] [Abstract] [Full Text] [Related]
6. PET Imaging of Estrogen Receptors Using
Kumar M; Salem K; Jeffery JJ; Fowler AM
Methods Mol Biol; 2022; 2418():129-151. PubMed ID: 35119664
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of super-resolution on 50 pancreatic cancer patients with real-time cine MRI from 0.35T MRgRT.
Chun J; Lewis B; Ji Z; Shin JI; Park JC; Kim JS; Kim T
Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34375963
[TBL] [Abstract] [Full Text] [Related]
8. Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma
Novera W; Lee ZW; Nin DS; Dai MZ; Binte Idres S; Wu H; Damen JMA; Tan TZ; Sim AYL; Long YC; Wu W; Huang RY; Deng LW
Antioxid Redox Signal; 2020 Dec; 33(17):1191-1208. PubMed ID: 32336105
[No Abstract] [Full Text] [Related]
9. YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Zhou Q; Bauden M; Andersson R; Hu D; Marko-Varga G; Xu J; Sasor A; Dai H; Pawłowski K; Said Hilmersson K; Chen X; Ansari D
J Transl Med; 2020 Feb; 18(1):77. PubMed ID: 32054505
[TBL] [Abstract] [Full Text] [Related]
10. Vocal cord paresis following single-session high intensity focused ablation (HIFU) treatment of benign thyroid nodules: incidence and risk factors.
Lang BHH; Woo YC; Chiu KW
Int J Hyperthermia; 2017 Dec; 33(8):888-894. PubMed ID: 28540836
[TBL] [Abstract] [Full Text] [Related]
11. Automatic tracking of arbitrarily shaped implanted markers in kilovoltage projection images: a feasibility study.
Regmi R; Lovelock DM; Hunt M; Zhang P; Pham H; Xiong J; Yorke ED; Goodman KA; Rimner A; Mostafavi H; Mageras GS
Med Phys; 2014 Jul; 41(7):071906. PubMed ID: 24989384
[TBL] [Abstract] [Full Text] [Related]
12. Fertility-sparing surgery for young women with early-stage epithelial ovarian cancer.
Nam JH; Park JY
Gynecol Obstet Invest; 2013; 76(1):14-24. PubMed ID: 23751891
[TBL] [Abstract] [Full Text] [Related]
13. Are there any specific ultrasound findings of nodular hyperplasia ("leave me alone" lesion) to differentiate it from follicular adenoma?
Moon WJ; Kwag HJ; Na DG
Acta Radiol; 2009 May; 50(4):383-8. PubMed ID: 19241229
[TBL] [Abstract] [Full Text] [Related]
14. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract] [Full Text] [Related]
15. Cyclic adenosine 3',5'-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type.
Keech CA; Jackson SM; Siddiqui SK; Ocran KW; Gutierrez-Hartmann A
Mol Endocrinol; 1992 Dec; 6(12):2059-70. PubMed ID: 1337142
[TBL] [Abstract] [Full Text] [Related]
